Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer - Wikidata - awgldk - TriplyDB

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

http://www.wikidata.org/entity/Q58568282

about

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

http://www.wikidata.org/entity/Q58568282

description

article publié dans Nature Communications

@fr

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Nature Communications

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@en

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@nl

type

label

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@en

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@nl

prefLabel

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@en

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@nl

P1433

Q58568282-0727A890-E6B4-4D77-8358-45B0FDE32AB6

P1476

Q58568282-6121FD98-C8AE-4ADF-9741-6B6697844EF0

P2093

Q58568282-064EC37E-165C-4B04-A54D-D7A01B4E62A0

Q58568282-0838272F-F63D-4246-AF9C-409169034314

Q58568282-314E3B27-2854-4E7D-9E24-5BCD42A8FF4C

Q58568282-33BEDD6D-EEDB-4FE2-A560-2E2A5FECF36F

Q58568282-44418539-D659-4EF1-9DEA-0FF186A371E4

Q58568282-4C3B397C-B21D-4927-BD3D-80E9046598CF

Q58568282-536D956C-C87C-4002-8941-58394CC231F6

Q58568282-5FA0DF52-764C-447C-92BD-D750A8A51054

Q58568282-63D9B579-160F-406F-AFF4-B3686CABA946

Q58568282-7F070151-C1CF-4757-9D3D-C68CAA19B3D7

P2860

Q58568282-03D2E027-3CF2-4622-BD33-2807EB17B23B

Q58568282-07E259F4-D0D9-4D1F-93EA-C17F5ACD5675

Q58568282-092F7B0B-952E-43E9-8D0A-4787A1316BF3

Q58568282-13D46AD7-717A-4EA7-A41E-29E59B94A91A

Q58568282-15DF02CD-507A-4812-9DDF-924B0F017C4B

Q58568282-16CF9D89-4DC6-4B6D-843A-8C5E2BC911A6

Q58568282-1A1A5EBE-91A5-4316-BAA5-3FA649F8824D

Q58568282-1C684F10-EEDF-427A-8572-912CE4451211

Q58568282-1E643FB8-4495-4D9E-A062-8C93BD7EC0A6

Q58568282-1FAED25C-F6FC-4F68-8335-EDEDFCD3200D

P2888

Q58568282-F52F4FB5-7574-41B6-AF4B-81F58AEAFC3A

P304

Q58568282-2BC59EE4-2E2B-4AB4-A24F-A8AAF48CFA6B

P31

Q58568282-0B29D589-2C16-4C83-B2FD-8F5ABA26285A

P356

Q58568282-C0D5F2D0-6AE5-40B1-A9D0-EA3C5B23BCED

P407

Q58568282-FC2E95AE-818F-4C64-BC08-27F8E53EBE1A

P433

Q58568282-072329A8-DC9A-438F-82DA-8023F1AE5DD3

P478

Q58568282-E0D12DC2-4877-45E3-A84A-81AEBAB956B2

P50

Q58568282-18A74E4A-641D-41F6-AC91-4020A02071F7

Q58568282-214BF215-C151-4886-8C14-C4E46F2602ED

Q58568282-29AF90BF-D58E-4507-9DA1-400EE365518C

Q58568282-503BCDBA-312A-46F8-A3B8-25D772950D81

Q58568282-9B075AF7-D8D4-4E41-9069-90A79E463855

P577

Q58568282-6F70B660-6179-4A31-ACE7-3ECF90D9F812

P698

Q58568282-D5930FB2-34F7-47FD-8B42-F3C7430D5F0D

P921

Q58568282-7B0AE161-23D8-49BC-939C-D866EE795832

P932

Q58568282-2AC6E234-8AFE-4E84-9E02-01F057333644

P356

S41467-018-07264-0

P1433

Nature Communications

P1476

Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer

@en

P2093

Cecil Han

http://www.w3.org/2001/XMLSchema#string

Cheng Huang

http://www.w3.org/2001/XMLSchema#string

Hanchen Xu

http://www.w3.org/2001/XMLSchema#string

Haniyeh Eyvani

http://www.w3.org/2001/XMLSchema#string

Hyun Ho Choi

http://www.w3.org/2001/XMLSchema#string

Jiangsheng Xu

http://www.w3.org/2001/XMLSchema#string

Jun Wan

http://www.w3.org/2001/XMLSchema#string

Lifei Wang

http://www.w3.org/2001/XMLSchema#string

Lu Zhang

http://www.w3.org/2001/XMLSchema#string

Michael Frieden

http://www.w3.org/2001/XMLSchema#string

P2860

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control

Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway

MicroRNAs: target recognition and regulatory functions

Comprehensive molecular portraits of human breast tumours

Noncoding RNAs in DNA repair and genome integrity

MicroRNA biogenesis pathways in cancer

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

P2888

s41467-018-07264-0

P304

4718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-07264-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Kevin Van der Jeught

P577

2018-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30413718

http://www.w3.org/2001/XMLSchema#string

P921

general chemistry

P932

6226492

http://www.w3.org/2001/XMLSchema#string